Search Results

There are 43269 results for: content related to: Phase II a randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing ‘off’ periods in patients with established Parkinson's disease

  1. Oral apomorphine delivery from solid lipid nanoparticleswith different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 547–557, Ming-Jun Tsai, Yaw-Bin Huang, Pao-Chu Wu, Yaw-Syan Fu, Yao-Ren Kao, Jia-You Fang and Yi-Hung Tsai

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22285

  2. DA agonists - Non-Ergot derivaties: Apomorphine

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S83–S89,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5567

  3. Dopaminergic regulation of orexin neurons

    European Journal of Neuroscience

    Volume 21, Issue 11, June 2005, Pages: 2993–3001, Michael Bubser, Jim R. Fadel, Lela L. Jackson, James H. Meador-Woodruff, Deqiang Jing and Ariel Y. Deutch

    Version of Record online : 24 JUN 2005, DOI: 10.1111/j.1460-9568.2005.04121.x

  4. You have free access to this content
    Modulation of secretion by dopamine involves decreases in calcium and nicotinic currents in bovine chromaffin cells.

    The Journal of Physiology

    Volume 427, Issue 1, August 1, 1990, Pages: 495–517, J M Sontag, P Sanderson, M Klepper, D Aunis, K Takeda and M F Bader

    Version of Record online : 1 AUG 1990, DOI: 10.1113/jphysiol.1990.sp018184

  5. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates

    Developmental Psychobiology

    Volume 25, Issue 7, November 1992, Pages: 475–495, Dalia R. Abrams and Dr. John P. Bruno

    Version of Record online : 13 OCT 2004, DOI: 10.1002/dev.420250703

  6. Update on Apomorphine for the Rapid Treatment of Hypomobility (“Off”) Episodes in Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 840–852, Dr. Crystal D. Obering, Dr. Jack J. Chen and Dr. David M. Swope

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.840

  7. You have free access to this content
    Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 6, June 2015, Pages: 468–475, Yudai Watanabe, Yuji Nakamura, Xin Cao, Hiroshi Ohara, Yukiko Yamazaki, Norie Murayama, Yosuke Sugiyama, Hiroko Izumi-Nakaseko, Kentaro Ando, Hiroshi Yamazaki and Atsushi Sugiyama

    Version of Record online : 22 NOV 2014, DOI: 10.1111/bcpt.12343

  8. You have free access to this content
    A study of tolerance to apomorphine

    British Journal of Pharmacology

    Volume 117, Issue 5, March 1996, Pages: 781–786, Jean-Louis Montastruc, Marie-Elise Llau, Jean-Michel Senard, Marie-Antoinette Tran, Olivier Rascol and Paul Montastruc

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15260.x

  9. You have free access to this content
    Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum

    British Journal of Pharmacology

    Volume 146, Issue 2, September 2005, Pages: 259–267, Kenshi Matsumoto, Masaki Yoshida, Karl-Erik Andersson and Petter Hedlund

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0706317

  10. Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rats


    Volume 67, Issue 7, July 2013, Pages: 363–373, Satoshi Fujita, Risako Kato, Yilong Cui, Masanori Terakado, Kurando Suga, Noriaki Koshikawa and Masayuki Kobayashi

    Version of Record online : 7 MAR 2013, DOI: 10.1002/syn.21644

  11. Dopamine agonists in Parkinson's disease: a look at apomorphine

    Fundamental & Clinical Pharmacology

    Volume 7, Issue 3-4, April 1993, Pages: 121–128, AJ Lees

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1472-8206.1993.tb00226.x

  12. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 10, October 2009, Pages: 3735–3747, Tsong-Long Hwang, Yin-Ku Lin, Chen-Hsien Chi, Tse-Hung Huang and Jia-You Fang

    Version of Record online : 20 JAN 2009, DOI: 10.1002/jps.21687

  13. You have free access to this content
    A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine

    British Journal of Pharmacology

    Volume 87, Issue 1, January 1986, Pages: 129–137, A.S. Davis, P. Jenner and C.D. Marsden

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1986.tb10164.x

  14. Apomorphine: An underutilized therapy for Parkinson's disease

    Movement Disorders

    Volume 15, Issue 5, September 2000, Pages: 789–794, Werner Poewe and Gregor K. Wenning

    Version of Record online : 23 JAN 2001, DOI: 10.1002/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H

  15. Apomorphine test for dopaminergic responsiveness: A dose assessment study

    Movement Disorders

    Volume 8, Issue 2, 1993, Pages: 158–164, Dr. U. Bonuccelli, P. Piccini, P. Del Dotto, G. Rossi, G. U. Corsini and A. Muratorio

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870080207

  16. Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans

    Movement Disorders

    Volume 10, Issue 1, January 1995, Pages: 28–36, Dr. Serge Przedborski, Marc Levivier, Christian Raftopoulos, Ali B. Naini and Jerzy Hildebrand

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870100107


    Journal of Neurochemistry

    Volume 30, Issue 5, May 1978, Pages: 1143–1148, John W. Kebabian

    Version of Record online : 12 DEC 2006, DOI: 10.1111/j.1471-4159.1978.tb12409.x

  18. Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 368–376, Olivier Rascol, Jean-Philippe Azulay, Olivier Blin, Anne-Marie Bonnet, Christine Brefel-Courbon, Pierre Césaro, Philippe Damier, Bérengère Debilly, Frank Durif, Monique Galitzky, Jean-Marie Grouin, Sylvie Pennaforte, Gabriel Villafane, Sadek Yaici and Yves Agid

    Version of Record online : 8 JAN 2010, DOI: 10.1002/mds.22922

  19. You have free access to this content
    Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated

    IUBMB Life

    Volume 62, Issue 5, May 2010, Pages: 371–376, Gabriella Fanali, Viviana Rampoldi, Alessandra di Masi, Alessandro Bolli, Leonardo Lopiano, Paolo Ascenzi and Mauro Fasano

    Version of Record online : 11 MAR 2010, DOI: 10.1002/iub.317


    Journal of the Experimental Analysis of Behavior

    Volume 98, Issue 3, November 2012, Pages: 273–282, Jonathan W. Pinkston and R. J. Lamb

    Version of Record online : 23 AUG 2013, DOI: 10.1901/jeab.2012.98-273